SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IVAX Insider Trading -- Ignore unavailable to you. Want to Upgrade?


To: flickerful who wrote (302)12/18/1997 9:17:00 AM
From: 5,17,37,5,101,...  Read Replies (2) | Respond to of 756
 
Immunex applied for generic version against breast cancer; Ivx for proprietary against K-S. According to Ivx 10K, FDA will not accept app. for generic version against B-C until 12/97 but Imm. filed anyway in summer 97 under pretense that 2 BM-S patents related to Pacli. were not legal patents. BM-S must have 4 by FDA rules. Needless to say, BM-S is fighting Imm. Also I wonder if Ivax is working on novel delivery (devilry) systems for Pacli/Pax. as stated in their 10K.
Jackson